BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 22170276)

  • 1. Is improvement in the quality of life after subthalamic nucleus stimulation in Parkinson's disease predictable?
    Daniels C; Krack P; Volkmann J; Raethjen J; Pinsker MO; Kloss M; Tronnier V; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G; Witt K
    Mov Disord; 2011 Dec; 26(14):2516-21. PubMed ID: 22170276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative impact of borderline global cognitive scores on quality of life after subthalamic nucleus stimulation in Parkinson's disease.
    Witt K; Daniels C; Krack P; Volkmann J; Pinsker MO; Kloss M; Tronnier V; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G
    J Neurol Sci; 2011 Nov; 310(1-2):261-6. PubMed ID: 21733529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life in advanced Parkinson's disease after bilateral subthalamic stimulation: 2 years follow-up study.
    Sobstyl M; Ząbek M; Górecki W; Mossakowski Z
    Clin Neurol Neurosurg; 2014 Sep; 124():161-5. PubMed ID: 25051167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilateral subthalamic nucleus stimulation improves health-related quality of life in Parkinsonian patients.
    Erola T; Karinen P; Heikkinen E; Tuominen J; Haapaniemi T; Koivukangas J; Myllylä V
    Parkinsonism Relat Disord; 2005 Mar; 11(2):89-94. PubMed ID: 15734666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of bilateral subthalamic stimulation on non-motor symptoms of Parkinson's disease.
    Nazzaro JM; Pahwa R; Lyons KE
    Parkinsonism Relat Disord; 2011 Sep; 17(8):606-9. PubMed ID: 21669545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic stimulation of the subthalamic nucleus increases daily on-time without dyskinesia in advanced Parkinson's disease.
    Portman AT; van Laar T; Staal MJ; Rutgers AW; Journee HL; Leenders KL
    Parkinsonism Relat Disord; 2006 Apr; 12(3):143-8. PubMed ID: 16460986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study.
    Witt K; Daniels C; Reiff J; Krack P; Volkmann J; Pinsker MO; Krause M; Tronnier V; Kloss M; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G
    Lancet Neurol; 2008 Jul; 7(7):605-14. PubMed ID: 18538636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significant improvement of motor symptoms by deep brain stimulation of bilateral subthalamic nucleus in patients with moderate or advanced Parkinson's disease].
    Chen J; Liu JL; Chen X; Qian H; Xian WB; Zhou HY; Liu YM; Ye XF; Zheng YF; Zhang SL; Chen L; Li JR; Liu ZL; Pei Z
    Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(5):291-5. PubMed ID: 21419000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.
    Spottke EA; Volkmann J; Lorenz D; Krack P; Smala AM; Sturm V; Gerstner A; Berger K; Hellwig D; Deuschl G; Freund HJ; Oertel WH; Dodel RC
    J Neurol; 2002 Jun; 249(6):759-66. PubMed ID: 12111311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for executive dysfunction after subthalamic nucleus stimulation in Parkinson's disease.
    Daniels C; Krack P; Volkmann J; Pinsker MO; Krause M; Tronnier V; Kloss M; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G; Witt K
    Mov Disord; 2010 Aug; 25(11):1583-9. PubMed ID: 20589868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors of subthalamic stimulation in Parkinson's disease: a comparative study between short- and long-term effects.
    Tsai ST; Lin SH; Chou YC; Pan YH; Hung HY; Li CW; Lin SZ; Chen SY
    Stereotact Funct Neurosurg; 2009; 87(4):241-8. PubMed ID: 19556833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life and depressive symptoms in Parkinson's disease after subthalamic deep brain stimulation: a 2-year follow-up study.
    Tykocki T; Szalecki K; Koziara H; Nauman P; Mandat T
    Turk Neurosurg; 2013; 23(3):379-84. PubMed ID: 23756979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's disease patients with subthalamic stimulation and carers judge quality of life differently.
    Lewis CJ; Maier F; Eggers C; Pelzer EA; Maarouf M; Moro E; Zurowski M; Kuhn J; Woopen C; Timmermann L
    Parkinsonism Relat Disord; 2014 May; 20(5):514-9. PubMed ID: 24637125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender differences in quality of life following subthalamic stimulation for Parkinson's disease.
    Hariz GM; Limousin P; Zrinzo L; Tripoliti E; Aviles-Olmos I; Jahanshahi M; Hamberg K; Foltynie T
    Acta Neurol Scand; 2013 Oct; 128(4):281-5. PubMed ID: 23550919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Change in fatigue after bilateral subthalamic nucleus deep brain stimulation for Parkinson's disease.
    Chou KL; Persad CC; Patil PG
    Parkinsonism Relat Disord; 2012 Jun; 18(5):510-3. PubMed ID: 22341622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of bilateral subthalamic nucleus stimulation in the treatment of Parkinson's disease: correlation with intra-operative multi-unit recordings but not with the type of anaesthesia.
    Lefaucheur JP; Gurruchaga JM; Pollin B; von Raison F; Mohsen N; Shin M; Ménard-Lefaucheur I; Oshino S; Kishima H; Fénelon G; Rémy P; Cesaro P; Gabriel I; Brugières P; Keravel Y; Nguyen JP
    Eur Neurol; 2008; 60(4):186-99. PubMed ID: 18667827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
    Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
    Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep brain stimulation parameters associated with neuropsychological changes in subthalamic nucleus stimulation for refractory Parkinson's disease.
    Schoenberg MR; Mash KM; Bharucha KJ; Francel PC; Scott JG
    Stereotact Funct Neurosurg; 2008; 86(6):337-44. PubMed ID: 18854660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease.
    Volkmann J; Albanese A; Kulisevsky J; Tornqvist AL; Houeto JL; Pidoux B; Bonnet AM; Mendes A; Benabid AL; Fraix V; Van Blercom N; Xie J; Obeso J; Rodriguez-Oroz MC; Guridi J; Schnitzler A; Timmermann L; Gironell AA; Molet J; Pascual-Sedano B; Rehncrona S; Moro E; Lang AC; Lozano AM; Bentivoglio AR; Scerrati M; Contarino MF; Romito L; Janssens M; Agid Y
    Mov Disord; 2009 Jun; 24(8):1154-61. PubMed ID: 19412954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.